| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antineoplastic and anti-inflammatory effects of bortezomib on systemic chronic active EBV infection
|
Yoshimori, Mayumi
|
|
|
5 |
7 |
p. 1805-1815
|
artikel
|
| 2 |
Autoimmune hypoglycemia expands the biological spectrum of HHV8+ multicentric Castleman disease
|
Arnautou, Pierre
|
|
|
5 |
7 |
p. 1848-1852
|
artikel
|
| 3 |
Caloric and nutrient restriction to augment chemotherapy efficacy for acute lymphoblastic leukemia: the IDEAL trial
|
Orgel, Etan
|
|
|
5 |
7 |
p. 1853-1861
|
artikel
|
| 4 |
CDX2 regulates ACE expression in blood development and leukemia cells
|
El Omar, Reine
|
|
|
5 |
7 |
p. 2012-2016
|
artikel
|
| 5 |
COVID-19 in individuals with sickle cell disease/trait compared with other Black individuals
|
Singh, Ashima
|
|
|
5 |
7 |
p. 1915-1921
|
artikel
|
| 6 |
Deciphering the mechanisms of CC-122 resistance in DLBCL via a genome-wide CRISPR screen
|
Mo, Zhongying
|
|
|
5 |
7 |
p. 2027-2039
|
artikel
|
| 7 |
Editorial Board
|
|
|
|
5 |
7 |
p. i
|
artikel
|
| 8 |
Electron microscopy shows that binding of monoclonal antibody PT25-2 primes integrin αIIbβ3 for ligand binding
|
Nešić, Dragana
|
|
|
5 |
7 |
p. 1781-1790
|
artikel
|
| 9 |
ETV6-FLT3–positive myeloid/lymphoid neoplasm with eosinophilia presenting in an infant: an entity distinct from JMML
|
Spitzer, Barbara
|
|
|
5 |
7 |
p. 1899-1902
|
artikel
|
| 10 |
Functional characterization of PD1+TIM3+ tumor-infiltrating T cells in DLBCL and effects of PD1 or TIM3 blockade
|
Roussel, Mikaël
|
|
|
5 |
7 |
p. 1816-1829
|
artikel
|
| 11 |
Health care resource utilization and cost burden of hemophilia B in the United States
|
Buckner, Tyler W.
|
|
|
5 |
7 |
p. 1954-1962
|
artikel
|
| 12 |
Heme activates platelets and exacerbates rhabdomyolysis-induced acute kidney injury via CLEC-2 and GPVI/FcRγ
|
Oishi, Saori
|
|
|
5 |
7 |
p. 2017-2026
|
artikel
|
| 13 |
Involved-site radiotherapy for Helicobacter pylori–independent gastric MALT lymphoma: 26 years of experience with 178 patients
|
Yahalom, Joachim
|
|
|
5 |
7 |
p. 1830-1836
|
artikel
|
| 14 |
Khurana A, Novo M, Nowakowski GS, et al. Clinical manifestations of, diagnostic approach to, and treatment of neurolymphomatosis in the rituximab era. Blood Adv. 2021;5(5):1379-1387.
|
|
|
|
5 |
7 |
p. 2053
|
artikel
|
| 15 |
Lyman GH, Carrier M, Ay C, et al. American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv. 2021;5(4):927-974.
|
|
|
|
5 |
7 |
p. 1953
|
artikel
|
| 16 |
Microenvironment immune reconstitution patterns correlate with outcomes after autologous transplant in multiple myeloma
|
Parmar, Harsh
|
|
|
5 |
7 |
p. 1797-1804
|
artikel
|
| 17 |
Minimally myelosuppressive regimen for remission induction in pediatric AML: long-term results of an observational study
|
Hu, Yixin
|
|
|
5 |
7 |
p. 1837-1847
|
artikel
|
| 18 |
Precocious clonal hematopoiesis in Down syndrome is accompanied by immune dysregulation
|
Liggett, L. Alexander
|
|
|
5 |
7 |
p. 1791-1796
|
artikel
|
| 19 |
Prognostic value of measurable residual disease after venetoclax and decitabine in acute myeloid leukemia
|
Maiti, Abhishek
|
|
|
5 |
7 |
p. 1876-1883
|
artikel
|
| 20 |
Prospective KIR genotype evaluation of hematopoietic cell donors is feasible with potential to benefit patients with AML
|
Shaffer, Brian C.
|
|
|
5 |
7 |
p. 2003-2011
|
artikel
|
| 21 |
Risk factors for seasonal human coronavirus lower respiratory tract infection after hematopoietic cell transplantation
|
Ogimi, Chikara
|
|
|
5 |
7 |
p. 1903-1914
|
artikel
|
| 22 |
Selective drug combination vulnerabilities in STAT3- and TP53-mutant malignant NK cells
|
Parri, Elina
|
|
|
5 |
7 |
p. 1862-1875
|
artikel
|
| 23 |
Srivaths L, Minard CG, O'Brien SH, et al. The spectrum and severity of bleeding in adolescents with low von Willebrand factor–associated heavy menstrual bleeding. Blood Adv. 2020;4(13):3209-3216.
|
|
|
|
5 |
7 |
p. 1952
|
artikel
|
| 24 |
Tetherin/BST2, a physiologically and therapeutically relevant regulator of platelet receptor signalling
|
Zhao, Xiaojuan
|
|
|
5 |
7 |
p. 1884-1898
|
artikel
|
| 25 |
The effect of platelet G proteins on platelet extravasation and tumor growth in the murine model of ovarian cancer
|
Cho, Min Soon
|
|
|
5 |
7 |
p. 1947-1951
|
artikel
|
| 26 |
The fatty acid elongase ELOVL6 regulates bortezomib resistance in multiple myeloma
|
Lipchick, Brittany C.
|
|
|
5 |
7 |
p. 1933-1946
|
artikel
|
| 27 |
The landscape of copy number variations in classical Hodgkin lymphoma: a joint KU Leuven and LYSA study on cell-free DNA
|
Buedts, Lieselot
|
|
|
5 |
7 |
p. 1991-2002
|
artikel
|
| 28 |
The potential of proliferative and apoptotic parameters in clinical flow cytometry of myeloid malignancies
|
Mestrum, Stefan G.C.
|
|
|
5 |
7 |
p. 2040-2052
|
artikel
|
| 29 |
The spleen as a sanctuary site for residual leukemic cells following ABT-199 monotherapy in ETP-ALL
|
Di Grande, Alessandra
|
|
|
5 |
7 |
p. 1963-1976
|
artikel
|
| 30 |
Transfer to the clinic: refining forward programming of hPSCs to megakaryocytes for platelet production in bioreactors
|
Evans, Amanda L.
|
|
|
5 |
7 |
p. 1977-1990
|
artikel
|
| 31 |
Zinc-dependent multimerization of mutant calreticulin is required for MPL binding and MPN pathogenesis
|
Rivera, Jeanne F.
|
|
|
5 |
7 |
p. 1922-1932
|
artikel
|
Tijdschrift beschrijving